Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-dose clopidogrel versus switch to prasugrel to overcome proton pump inhibitor interaction
2010-019154-40Phase 3Active
- Sponsor
- Medco Health Solutions
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clopidogrel, prasugrel and lansoprazole in coronary arteriosclerosis (2 arms), sponsored by Medco Health Solutions. Started Mar 2010; status: active.
02
Drugs
clopidogrelprasugrellansoprazole
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2010-019154-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019154-40.